Product Images Pirfenidone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Pirfenidone NDC 72205-182 by Novadoz Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a product label for Pirfenidone Tablets made by Novadoz. The label includes information such as the name of the medication, the manufacturer, the dosage and quantity of tablets, and a lot number and expiration date. The illegible text makes it difficult to discern any additional details.*
This is a medication package for Pirfenidone tablets distributed by Novadoz Pharmaceuticals LLC. The package contains 30 tablets and the usual dosage information can be found in the package insert. The tablets should be stored at 25°C (77°F) with excursions permitted. The manufacturer is MSN Laboratories Private Limited in Telangana, India. The package also includes the relevant product codes and issue dates.*
This is a product description for Novadoz Pirfenidone Tablets in a package containing 90 tablets divided into 3 bottles of 30 tablets each. The NDC code is 72205-181-36 and the batch number is 220518138. The drug is used for the treatment of idiopathic pulmonary fibrosis.*
This is a medication called Pirfenidone contained in film-coated tablets. Each tablet contains 801mg of the medication. The usual dosage instructions can be found in the package insert. The medication should be kept at a temperature between 15-30°C and must be kept out of children's reach. It is manufactured by WISN Laboratories Private Limited in Telangana, India and distributed by B A in Pscataway, X in a package of 30 tablets. The M.L.No. is 5/MN/TS/2014/F/G.*
This appears to be a survival analysis study that compares the impact of Pirfenidone vs placebo on patients' survival. There were 623 patients in the Pirfenidone group and 624 in the placebo group. The percentage of patients alive was measured over time, and a Hazard Ratio (HR) was calculated with a 95% Confidence Interval (CI) of 0.75 (0.51 - 1.11). The study followed patients for up to 120 weeks, and the number of patients at risk decreased over time for both groups.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.